Clinical Trials · NCT07403604

Effect of Insulin Lowering on Lipogenesis

Phase
Phase 1
Recruitment status
Recruiting
Sponsor
Columbia University
Enrollment
25
Start date
May 2026
Locations
1 site, United States
Primary endpoint
Hepatic de novo lipogenesis (absolute values)
View Octreotide compound reference